MBX vs REGN: Which Stock is Better?
Side-by-side comparison of Mbx Biosciences Inc and Regeneron Pharmaceuticals Inc in 2026
MBX
Mbx Biosciences Inc
$28.00
REGN
Regeneron Pharmaceuticals Inc
$745.77
Key Metrics Comparison
| Metric | MBX | REGN | Winner |
|---|---|---|---|
| Market Cap | $1.26B | $78.84B | REGN |
| P/E Ratio | 3.65 | 17.99 | MBX |
| EPS (TTM) | $7.67 | $41.46 | REGN |
| Revenue Growth | 0.0% | 0.0% | REGN |
| Gross Margin | 0.0% | 44.6% | REGN |
Analyze MBX
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MBX or REGN a better investment?
Comparing MBX and REGN: Mbx Biosciences Inc has a market cap of $1.26B while Regeneron Pharmaceuticals Inc has $78.84B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MBX and REGN?
MBX (Mbx Biosciences Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MBX or REGN?
Based on P/E ratios, MBX trades at a lower multiple (3.7x vs 18.0x).
Which is growing faster: MBX or REGN?
REGN has higher revenue growth at 0.0% vs 0.0% for MBX.
Which company is more profitable: MBX or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for MBX.
Which is the larger company: MBX or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $78.84B compared to $1.26B for MBX.
Should I buy MBX or REGN in 2026?
Both MBX and REGN have investment merit. MBX trades at $28.00 while REGN trades at $745.77. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MBX and REGN stock?
Key differences: Market Cap ($1.26B vs $78.84B), P/E Ratio (3.7x vs 18.0x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 44.6%).